Aclarion Adds UHealth University Of Miami Miller School Of Medicine As CLARITY Trial Site To Validate Nociscan's AI-Driven MR Spectroscopy For Chronic Low Back Pain Surgery

Company announced the addition of UHealth — University of Miami Health System and the University of Miami Miler School of Medicine as a CLARITY (Chronic Low bAck pain Randomized Independent Trial studY) trial site. The landmark CLARITY study is designed to demonstrate Nociscan's clinical and economic value in spine surgery.

"I have a particular interest in ‘ultra-minimally' invasive approaches to the spine including endoscopic spine surgery," said Gregory Basil, MD, of UHealth who is also Director of Endoscopic Spine Surgery and Assistant Professor at the University of Miami Miller School of Medicine, University of Miami. "We believe in customizing treatments to each patient's pathology, goals, needs, and lifestyle, and in this regard, leveraging novel technologies, like Nociscan, to better understand our patient's low back pain for personalized treatments. The CLARITY trial is a unique opportunity for me and my colleagues at the Miller School of Medicine to advance the spine industry and showcase the research capabilities at the University of Miami."